Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C.

Abstract

Interferon (IFN) results in normalization of the serum alanine aminotransferase (ALT), loss of detectable serum hepatitis C virus (HCV) RNA, and histologic improvement in approximately 40% of patients. However, regardless of the duration of initial therapy, most patients relapse within the first few months after the drug is stopped and only a small… (More)

Topics

Cite this paper

@article{Davis1999CombinationTW, title={Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C.}, author={Gary L. Davis}, journal={Seminars in liver disease}, year={1999}, volume={19 Suppl 1}, pages={49-55} }